Devdiscourse1h
Drugmakers Battle Against Tariffs on Medicinal Goods
The pharmaceutical industry is urging the Trump administration and European Union to exclude medical goods from tariff ...
Fierce Pharma3h
IRA round 2 begins as drugmakers sign on to price negotiation process with CMS
Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...
Drugmakers agree to participate in second round of price negotiations
All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...
Trump’s HHS Backs Rejection of Drug Discount Plan Rebate Model
The Trump administration is defending a Biden-era decision to reject drug manufacturer plans that would allow them to discount medicines through a rebate rather than up front under a federal drug ...
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
Mallinckrodt and Endo , drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced ...
Becker's Hospital Review2h
HHS files brief in 340B rebate model case: 4 takeaways
HHS has filed a legal brief urging a federal judge to dismiss lawsuits brought by pharmaceutical companies challenging the agency’s stance on 340B rebate models. Here are four takeaways: ...
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from the tariff wars, Maggie Fick of ...
Drugmakers Mallinckrodt and Endo Are in Talks to Merge
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...
Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal
Mallinckrodt and Endo, drugmakers with a shared history of facing bankruptcy and U.S. opioid litigation, have agreed to merge ...
STAT3d
U.K. plan to require drugmakers to pay higher rebates draws criticism from industry group
The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.
Drugmakers Mallinckrodt, Endo to Merge, Plan NYSE Listing
Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York ...
Colorado bill would remake federal program that subsidizes hospitals in bid to lower patients’ costs
During the pandemic, hospitals expanded the amount of 340B revenue they took in by partnering with other pharmacies, and drug makers retaliated by limiting those partnerships.